The NVX-CoV2373 COVID-19 vaccine offers significant protection against symptomatic infections, but its effectiveness against SARS-CoV-2 declines within four months, according to a study in JAMA Network Open using Italian data. However, its protection against symptomatic COVID-19 seems to remain stable during this period.
Missouri Patient Tests Positive for Bird Flu Despite No Known Exposure to Animals
A hospitalized patient in Missouri was infected with bird flu despite having had no known contact with dairy cows or other animals associated with an
September 8, 2024